These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 28793993

  • 1. Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial.
    Tribler S, Brandt CF, Petersen AH, Petersen JH, Fuglsang KA, Staun M, Broebech P, Moser CE, Jeppesen PB.
    Am J Clin Nutr; 2017 Sep; 106(3):839-848. PubMed ID: 28793993
    [Abstract] [Full Text] [Related]

  • 2. A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients.
    Gudiol C, Arnan M, Aguilar-Guisado M, Royo-Cebrecos C, Sánchez-Ortega I, Montero I, Martín-Gandul C, Laporte-Amargós J, Albasanz-Puig A, Nicolae S, Perayre M, Berbel D, Tebe C, Riera J, Sureda A, Cisneros JM, Carratalà J.
    Antimicrob Agents Chemother; 2020 Jan 27; 64(2):. PubMed ID: 31712211
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of taurolidine-citrate in a cohort of patients with intestinal failure receiving home parenteral nutrition.
    Williams TJ, Moy N, Kaazan P, Callaghan G, Holtmann G, Martin N.
    JPEN J Parenter Enteral Nutr; 2024 Feb 27; 48(2):165-173. PubMed ID: 38062902
    [Abstract] [Full Text] [Related]

  • 4. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
    Gudiol C, Nicolae S, Royo-Cebrecos C, Aguilar-Guisado M, Montero I, Martín-Gandul C, Perayre M, Berbel D, Encuentra M, Arnan M, Cisneros-Herreros JM, Carratalà J.
    Trials; 2018 May 02; 19(1):264. PubMed ID: 29720244
    [Abstract] [Full Text] [Related]

  • 5. Taurolidine lock in home parenteral nutrition in adults: results from an open-label randomized controlled clinical trial.
    Klek S, Szczepanek K, Hermanowicz A, Galas A.
    JPEN J Parenter Enteral Nutr; 2015 Mar 02; 39(3):331-5. PubMed ID: 24604029
    [Abstract] [Full Text] [Related]

  • 6. Strategies to Reduce Catheter-Related Bloodstream Infections in Pediatric Patients Receiving Home Parenteral Nutrition: The Efficacy of Taurolidine-Citrate Prophylactic-Locking.
    Lambe C, Poisson C, Talbotec C, Goulet O.
    JPEN J Parenter Enteral Nutr; 2018 Aug 02; 42(6):1017-1025. PubMed ID: 29385236
    [Abstract] [Full Text] [Related]

  • 7. A 2% taurolidine catheter lock solution prevents catheter-related bloodstream infection (CRBSI) and catheter dysfunction in hemodialysis patients.
    Neusser MA, Bobe I, Hammermeister A, Wittmann U.
    Br J Nurs; 2021 Jul 22; 30(14):S24-S32. PubMed ID: 34288746
    [Abstract] [Full Text] [Related]

  • 8. Taurolidine and Heparin as Catheter Lock Solution for Central Venous Catheters in Hemodialysis.
    Nguyen T, Camins BC, Butler DA.
    Am J Ther; 2021 Jul 22; 31(4):e398-e409. PubMed ID: 38710029
    [Abstract] [Full Text] [Related]

  • 9. Catheter salvage or removal in catheter-related bloodstream infections with Staphylococcus aureus in children with chronic intestinal failure receiving home parenteral nutrition and the use of prophylactic taurolidine catheter lock solution: A descriptive cohort study.
    Demirok A, Illy DHC, Nagelkerke SQ, Lagerweij MF, Benninga MA, Tabbers MM.
    JPEN J Parenter Enteral Nutr; 2024 May 22; 48(4):486-494. PubMed ID: 38605559
    [Abstract] [Full Text] [Related]

  • 10. Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition.
    Wouters Y, Theilla M, Singer P, Tribler S, Jeppesen PB, Pironi L, Vinter-Jensen L, Rasmussen HH, Rahman F, Wanten GJA.
    Aliment Pharmacol Ther; 2018 Aug 22; 48(4):410-422. PubMed ID: 29978597
    [Abstract] [Full Text] [Related]

  • 11. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Winnicki W, Herkner H, Lorenz M, Handisurya A, Kikić Ž, Bielesz B, Schairer B, Reiter T, Eskandary F, Sunder-Plassmann G, Sengoelge G.
    Kidney Int; 2018 Mar 22; 93(3):753-760. PubMed ID: 28890326
    [Abstract] [Full Text] [Related]

  • 12. Clinical outcomes of home parenteral nutrition patients using taurolidine as catheter lock: A long-term cohort study.
    Wouters Y, Roosenboom B, Causevic E, Kievit W, Groenewoud H, Wanten GJA.
    Clin Nutr; 2019 Oct 22; 38(5):2210-2218. PubMed ID: 30292482
    [Abstract] [Full Text] [Related]

  • 13. Taurolidine/Heparin Lock Solution and Catheter-Related Bloodstream Infection in Hemodialysis: A Randomized, Double-Blind, Active-Control, Phase 3 Study.
    Agarwal AK, Roy-Chaudhury P, Mounts P, Hurlburt E, Pfaffle A, Poggio EC.
    Clin J Am Soc Nephrol; 2023 Nov 01; 18(11):1446-1455. PubMed ID: 37678222
    [Abstract] [Full Text] [Related]

  • 14. Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock.
    Chu HP, Brind J, Tomar R, Hill S.
    J Pediatr Gastroenterol Nutr; 2012 Oct 01; 55(4):403-7. PubMed ID: 22595973
    [Abstract] [Full Text] [Related]

  • 15. Use of Catheter Lock Solutions in Patients Receiving Home Parenteral Nutrition: A Systematic Review and Individual-Patient Data Meta-Analysis.
    Wouters Y, Causevic E, Klek S, Groenewoud H, Wanten GJA.
    JPEN J Parenter Enteral Nutr; 2020 Sep 01; 44(7):1198-1209. PubMed ID: 31985068
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of taurolidine on the prevention of catheter-related bloodstream infections in patients on home parenteral nutrition.
    Al-Amin AH, Sarveswaran J, Wood JM, Burke DA, Donnellan CF.
    J Vasc Access; 2013 Sep 01; 14(4):379-82. PubMed ID: 23817948
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical and economic impact of the taurolidine lock on home parenteral nutrition.
    Arnoriaga Rodríguez M, Pérez de Ciriza Cordeu M, Camblor Álvarez M, Bretón Lesmes I, Motilla de la Cámara M, Velasco Gimeno C, Arhip L, García Peris P, Cuerda Compés C.
    Nutr Hosp; 2018 Jun 28; 35(4):761-766. PubMed ID: 30070861
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Meta-analysis of the efficacy of taurolidine in reducing catheter-related bloodstream infections for patients receiving parenteral nutrition.
    Vernon-Roberts A, Lopez RN, Frampton CM, Day AS.
    JPEN J Parenter Enteral Nutr; 2022 Sep 28; 46(7):1535-1552. PubMed ID: 35233792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.